Vertex Pharmaceuticals (VRTX) EBIT Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.09% |
| Dec 31, 2025 | 10.09% |
| Sep 30, 2025 | 12.03% |
| Jun 30, 2025 | 9.90% |
| Mar 31, 2025 | -2.64% |
| Dec 31, 2024 | 13.22% |
| Sep 30, 2024 | 62.23% |
| Jun 30, 2024 | -71.92% |
| Mar 31, 2024 | 32.71% |
| Dec 31, 2023 | 50.57% |
| Sep 30, 2023 | 38.24% |
| Jun 30, 2023 | 42.80% |
| Mar 31, 2023 | 43.30% |
| Dec 31, 2022 | 52.39% |
| Sep 30, 2022 | 40.40% |
| Jun 30, 2022 | 83.82% |
| Mar 31, 2022 | 30.90% |
| Dec 31, 2021 | 85.80% |
| Sep 30, 2021 | 125.50% |
| Jun 30, 2021 | -67.80% |
| Mar 31, 2021 | 129.71% |
| Dec 31, 2020 | 73.86% |
| Sep 30, 2020 | 63.26% |
| Jun 30, 2020 | 44.02% |
| Mar 31, 2020 | 43.98% |
| Dec 31, 2019 | 41.08% |
| Sep 30, 2019 | 21.96% |
| Jun 30, 2019 | 28.44% |
| Mar 31, 2019 | 26.83% |
| Dec 31, 2018 | 70.53% |
| Sep 30, 2018 | 29.66% |
| Jun 30, 2018 | 41.52% |
| Mar 31, 2018 | 18.13% |
| Dec 31, 2017 | 29.36% |
| Sep 30, 2017 | -213.83% |
| Jun 30, 2017 | 47.13% |
| Mar 31, 2017 | 24.20% |
| Dec 31, 2016 | -29.27% |
| Sep 30, 2016 | -15.85% |
| Mar 31, 2016 | 38.27% |
| Dec 31, 2015 | 20.27% |
| Sep 30, 2015 | 18.90% |
| Jun 30, 2015 | -0.19% |
| Mar 31, 2015 | -1.42% |
| Dec 31, 2014 | -0.92% |
| Sep 30, 2014 | 0.83% |
| Jun 30, 2014 | -2.81% |
| Mar 31, 2014 | -5.94% |